Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for ...

Discover five promising Prader-Willi syndrome therapies climbing the clinical ladder and nearing FDA approval in the coming ...

BIOSPAIN showed how partnering conferences connect public funding, venture capital, and pharma to drive biotech innovation to ...

Home to a well-established hub with strong investment and startup activity, discover what makes Cambridge's biotech scene so ...

Discover how AKIGAI’s EGFR inhibitors may redefine neuropathic pain therapy and offer hope for complex regional pain syndrome ...

Discover the top biotech deals of September 2025, as four billion-dollar acquisitions took place and several licensing deals ...

The Asabys-Aliath integration signals how European biotech VCs are scaling and adapting amid funding pressures.

The Nordic Life Science (NLS) Days took place this week, October 13–14, in Gothenburg, Sweden. Labiotech was on site to take the pulse of the Nordic biotech scene, and, more specifically, of Sweden’s ...

Qure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025.

The U.K. has had a stronghold on the biopharma and healthcare industry for a long time and remains one of the top hubs for life science research. So, Merck’s decision to back out of its $1 billion ...

A company that hardly needs an introduction is Eli Lilly, but what has it been up to lately, and what’s its pipeline strategy? Over the past year, Lilly has mixed headline-grabbing science with ...